ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update

Company Signs License Agreement With Boyalife Genomics and will Form TG Biosynthesis Division to Operate as CDMO for Cell and Cell-Based Gene Therapies Leases 35,475 SF To Be Built-Out as cGMP Compliant Facility in Sacramento Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET...

Click to view original post